SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EBIO: Epoch Pharmaceuticals

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dalroi who wrote (23)9/8/2004 1:48:28 PM
From: tuck   of 33
 
EBIO being munched by NGEN, and the rationale for anyone is hard to figure. Perhaps the Grace Brothers, and Dr. Craves, the original CEO, current chairman and Bay City Capital principal, cashed in their cheapest options ($.50) by last year. And started looking for a way out. The rest of their options, with some years left on them, are for much higher prices, so they write those off or hope NGEN actually survives -- which I doubt. But they'd still walk away with a healthy profit. EBIO shareholders, on the other hand, would need to have bought under $2 to get much. Even Gerber doesn't get much here. I wonder if other shareholders would fight the deal. If I'm right . . . Bay City and The Grace Bros. own about 40% of the company, so it would have to be a united front.

You still hold any, Stefaan? I'll be looking to get my Mom out of her shares soon. Don't like the deal, nor NGEN's prospects.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext